Pharmaceutical companies are increasingly focusing on radiopharmaceuticals as a promising new approach to cancer treatment. Major companies like Bristol Myers Squibb, AstraZeneca, and Eli Lilly have invested billions in acquiring or partnering with radiopharmaceutical makers to develop treatments that deliver radiation directly to tumors. These drugs, though in their infancy, show significant potential in treating… Continue reading Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

A new analysis by health policy research organization KFF reveals that over 57 million insured U.S. adults under 65 could be eligible for popular weight loss and diabetes medications called GLP-1s, such as Novo Nordisk’s Wegovy and Ozempic. These drugs, approved for treating Type 2 diabetes and obesity, can help patients with weight-related health conditions… Continue reading Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs

The American Red Cross recently declared an emergency blood shortage due to a 25% drop in supply in July. Safi Biotherapeutics, a four-year-old startup led by CEO Doug McConnell, is working on a solution by developing lab-grown blood to reduce reliance on donations. Current methods of growing red blood cells from stem cells are costly… Continue reading This government-backed startup is growing blood to help fight shortages

Toronto, Canada — TheNewswire — September 9, 2024 — Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”), (TSXV:VPT; OTCQB:VPTDF), a leading provider of innovative cardiac diagnostic solutions, is pleased to announce the launch of its new reference site programme. This initiative aims to foster collaboration with key stakeholders in major hospitals to enhance the accuracy, efficiency… Continue reading Ventripoint to Launch Reference Site Programme to Deepen Collaborations with Hospital Partners

TORONTO, Ontario, Sept. 09, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that Titan management will host a webcast Q&A session on Thursday, September 19, 2024 at 5:00 pm ET in connection with filing and mailing of the management information circular, which was announced by press release issued on September… Continue reading Titan Announces Q&A Session with Shareholders

Abbott Laboratories has launched Lingo, an over-the-counter continuous glucose monitor, now available in the U.S. starting at $49. Lingo is part of a new wave of consumer-friendly biosensors designed to help individuals track their glucose levels to enhance overall health and wellness, rather than manage diabetes. Unlike traditional continuous glucose monitors intended for diabetes patients,… Continue reading Abbott launches its first over-the-counter continuous glucose monitor in the U.S.

Earlier this month, Berkshire Hathaway reached a historic milestone by surpassing a $1 trillion market value, becoming the first non-tech company in the U.S. to achieve this feat. Eli Lilly, a major pharmaceutical company, is poised to follow in its footsteps and become the first healthcare company to join this elite club. Eli Lilly’s potential… Continue reading Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock

SUNNYVALE, Calif., Sept. 5, 2024 /PRNewswire/ – Willow Biosciences Inc. (“Willow“) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable ingredients, announces signing a commercial license and royalty agreement with Kalsec, Inc. (“Kalsec“), a leading global producer of natural taste and sensory, food protection, colors and advanced hops ingredients… Continue reading WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.

VANCOUVER, BC, Sept. 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys” or the Company”) is pleased to announce that it has been invited to present “A Novel Delivery System for Personalized Peptide & mRNA Vaccines for More Targeted Therapies” at The Personalized Cancer Vaccine Summit (formerly known as the… Continue reading BioVaxys to Present New Data on its DPX Immune Educating Platform at Personalized Cancer Vaccine Summit

Eli Lilly has introduced a more affordable version of its weight loss drug, Zepbound, aiming to make it accessible to a broader population, particularly those without insurance, such as Medicare beneficiaries. The newly released single-dose vials are priced at $399 for 2.5-milligram and $549 for 5-milligram doses per month, significantly lower than the typical $1,000… Continue reading Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply

The article provides an overview of the upcoming availability of new COVID-19 vaccines in the U.S. The FDA recently approved updated mRNA-based vaccines from Pfizer and Moderna, targeting a new strain called KP.2, a descendant of the omicron subvariant JN.1. Despite KP.2 accounting for only 3% of cases as of mid-August, the vaccines are expected… Continue reading Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines

Dexcom recently launched Stelo, its new over-the-counter continuous glucose monitor (CGM), available for purchase in the U.S. for individuals with prediabetes or Type 2 diabetes who do not use insulin. Unlike Dexcom’s previous CGMs, Stelo does not require a prescription, making it accessible to millions of Americans with prediabetes or Type 2 diabetes who previously… Continue reading Dexcom launches first over-the-counter continuous glucose monitor. Here’s what it’s like